1. David Malek, VP Business Development
BD Presentation
David Malek, VP Business Development
BioLineRx

2. Forward Looking Statements
This presentation contains "forward-looking statements." These statements include words like "may," "expects," "believes," “plans,” “scheduled," and "intends," and describe opinions about future events. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of BioLineRx to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

3. BioLineRx - General
Founded in 2003 by Teva and other key players in Israeli Life Sciences industry
Bridge “development gap” for Israeli assets
Leverage carefully selected early-stage technology, primarily at academia level, following proof of concept in animals (at a minimum)
Invest 3-6 years in asset through to major catalyst
Partner the asset (depending on the stage)
Current pipeline of 10 assets, 6 in clinical development
~55 employees, of which ~40 with advanced degrees

4. Efficient Project Development Infrastructure
Expert Project Managers
Medical and Clinical Team BD
In-licensing and Out-licensing
Multiple
Projects
Pre-Clinical Team
Our expert teams work in synergy to advance the projects as quickly and efficiently as possible
Chemistry Team
(Organic, Analytical, Bioanalytical, Formulation)
Intellectual Property Experts
Regulatory Affairs Team

5. What is BD in biopharma companies? Example via biolinerx

6. In BioLineRx, BD Has 3 Major Responsibilities
Scouting & in-licensing
Search for innovative and attractive projects, in Israel and abroad
Evaluate projects: science, development, clinical need, commercial opportunity, IP
Negotiate with inventors and manage the alliance
Out-licensing
The way in which most companies make revenues
Identify partners, contact them, present and persuade, manage relationship
Negotiate and manage the alliance
“Commercial Sense”
Identify best value for the project from the commercial perspective
Collaborate with R&D to find overlap between commercial potential, scientific fit and development feasibility
Continuously monitor and analyze the impact of changes in the market/data

7. The Team Structure Supports These Roles
Scout
Gideon Stein
Scout
Portfolio Manager
Lior Teitelbaum
Scientific Evaluation Leader
Victoria Balannik
Out Licensing
Tomer Bahar
Analyst
Inbal Michaelovici

8. Career paths to bd roles

9. What is the Background of the Team Members?
Education: MD, MBA
Experience: physician, entrepreneur
Gideon Stein
Education: MSc., MBA
Experience: VC analyst, small medical device company
Lior Teitelbaum
Education: PhD
Experience: Post-doc, researcher, Amazon
Victoria Balannik
Education: MSc., MBA
Experience: PwC, Hadasit
Tomer Bahar
Education: PhD
Experience: Researcher
Inbal Michaelovici

10. What Are the Key Career Paths?
Direct to industry
Typically junior
Better chance at companies with larger BD teams, TTOs
Investment community
Relatively few positions, more in the lines of temporary experience
Typically analyst positions
R&D first
Work for several years in R&D roles and try to “progress” to BD
Typically easier within the same company
Can also work for entrepreneurs
Service Industry
“satellite” companies supporting the industry: IP law firms, accounting firms, etc.

11. תכל'ס, מה לעשות? Read business news and literature all the time
Free sources are fine: FierceBiotech, FirstWord, etc.
Gain as wide a base as possible in your academic experience
In BD, over-specialization is typically NOT a good thing
Show you’re a fast-learner (which you’ll need to be in order to switch to business)
Get some part-time experience/project
Create some level of confidence and differentiation
You will learn a lot about the fit
Network (with the relevant people)
Strong labs/recommendations help
MBA: only if you really want to
Don’t be afraid to take tasks that you have no experience/qualifications for